From: Risk factors affecting outcome of rhino-orbital-cerebral mucormycosis in COVID-19 patients
 | Total no. = 33 |
---|---|
CT PNS | |
 Rt max. S | 16 (48.5%) |
 Lt max. S | 26 (78.8%) |
 Rt ethmoid | 20 (60.6%) |
 Lt ethmoids | 27 (81.8%) |
 Rt sphenoid | 19 (57.6%) |
 Lt sphenoid | 24 (72.7%) |
 Rt frontal | 13 (39.4%) |
 Lt frontal | 15 (45.5%) |
 Bony erosions | 17 (51.5%) |
 Bilateral involvement | 14 (42.4%) |
COVID status | |
 Previous COVID | 22 (66.7%) |
 PCR at presentation | 6 (18.2%) |
CT CO-RAD score | |
 Median (IQR) | 3 (1–4) |
 Range | 1–5 |